title: Incorporation of monodisperse oligoethyleneglycol amino acids into anticonvulsant analogues of galanin and neuropeptide y provides peripherally acting analgesics.
abstract: Delivery of neuropeptides into the central and/or peripheral nervous systems supports development of novel neurotherapeutics for the treatment of pain, epilepsy and other neurological diseases. Our previous work showed that the combination of lipidization and cationization applied to anticonvulsant neuropeptides galanin (GAL) and neuropeptide Y (NPY) improved their penetration across the blood-brain barrier yielding potent antiepileptic lead compounds, such as Gal-B2 (NAX 5055) or NPY-B2. To dissect peripheral and central actions of anticonvulsant neuropeptides, we rationally designed, synthesized and characterized GAL and NPY analogues containing monodisperse (discrete) oligoethyleneglycol-lysine (dPEG-Lys). The dPEGylated analogues Gal-B2-dPEG(24), Gal-R2-dPEG(24) and NPY-dPEG(24) displayed analgesic activities following systemic administration, while avoiding penetration into the brain. Gal-B2-dPEG(24) was synthesized by a stepwise deprotection of orthogonal 4-methoxytrityl and allyloxycarbonyl groups, and subsequent on-resin conjugations of dPEG(24) and palmitic acids, respectively. All the dPEGylated analogues exhibited substantially decreased hydrophobicity (expressed as logD values), increased in vitro serum stabilities and pronounced analgesia in the formalin and carrageenan inflammatory pain assays following systemic administration, while lacking apparent antiseizure activities. These results suggest that discrete PEGylation of neuropeptides offers an attractive strategy for developing neurotherapeutics with restricted penetration into the central nervous system.
authors.affiliation: Department of Medicinal Chemistry, College of Pharmacy, University of Utah , Salt Lake City, Utah 84108, United States.
authors.forename: Liuyin
authors.initials: L
authors.lastname: Zhang
authors.forename: Brian D
authors.initials: BD
authors.lastname: Klein
authors.forename: Cameron S
authors.initials: CS
authors.lastname: Metcalf
authors.forename: Misty D
authors.initials: MD
authors.lastname: Smith
authors.forename: Daniel R
authors.initials: DR
authors.lastname: McDougle
authors.forename: Hee-Kyoung
authors.initials: HK
authors.lastname: Lee
authors.forename: H Steve
authors.initials: HS
authors.lastname: White
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Bulaj
mesh_terms: D000596:Amino Acids / Q000737:chemistry*; D000700:Analgesics / Q000737:chemistry*; D000818:Animals; D000927:Anticonvulsants / Q000737:chemistry* / Q000494:pharmacology; D019004:Galanin / Q000031:analogs & derivatives* / Q000737:chemistry; D008297:Male; D051379:Mice; D009478:Neuropeptide Y / Q000031:analogs & derivatives* / Q000737:chemistry; D059225:Nociception / Q000187:drug effects
chemical_list: D000596:Amino Acids; D000700:Analgesics; D000927:Anticonvulsants; D009478:Neuropeptide Y; D019004:Galanin